| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |